SCHEMBL20735027

SCHEMBL20735027

CCCCCC(CC)N1C(=O)c2cccc3c(-c4ccc(-c5cccnc5)cc4)ccc(c23)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHPS P49366 3/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CYP1B1 Q16678 1/20 0.38
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ DHODH Q02127 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735095 0.95 DHPS (0.44) DHPSCYP1B1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL20735194 0.93 DHPS (0.43) DHPSCYP1B1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL20735028 0.90 CYP1B1 (0.38) DHPSCYP3A4CYP2D6CYP1B1SMN1; SMN2
SCHEMBL20735022 0.90 KMT2A (0.40) CYP1B1MEN1POLBMAPTMAPK1
SCHEMBL20735024 0.90 KMT2A (0.40) CYP1B1MEN1POLBMAPTMAPK1
SCHEMBL23340424 0.89 KMT2A (0.41) CYP1B1MEN1POLBMAPTMAPK1
SCHEMBL20735035 0.89 KMT2A (0.41) CYP1B1MEN1POLBMAPTMAPK1
SCHEMBL20735209 0.88 CYP1B1 (0.39) DHPSCYP1B1SMN1; SMN2MEN1POLB
SCHEMBL23340418 0.87 CYP1B1 (0.38) DHPSCYP1B1SMN1; SMN2MEN1POLB
SCHEMBL20735188 0.86 KMT2A (0.40) CYP1B1SMN1; SMN2MEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
EP-3442047-B1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO LTD (KR) 2021-05-05 — — EP disclosed
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed
US-20190051856-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS ALDH1A1, AOX1, ALDH1A2 DHPS 2640/4885CYP3A4 1565/4885CYP2D6 1125/4885
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit ALDH1A1, AOX1, AMY1A DHPS 2612/4885CYP3A4 1836/4885CYP2D6 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback